Challenges and Advances in Targeting Remission in Axial Spondyloarthritis

J Rheumatol. 2018 Feb;45(2):153-157. doi: 10.3899/jrheum.170222.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Biological Therapy*
  • Biomarkers / analysis
  • C-Reactive Protein / analysis
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Physician-Patient Relations
  • Remission Induction
  • Spondylitis, Ankylosing / diagnostic imaging
  • Spondylitis, Ankylosing / therapy*
  • Terminology as Topic
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Biomarkers
  • TNF protein, human
  • Tumor Necrosis Factor-alpha
  • C-Reactive Protein